TITLE

Prevention and management of osteoporosis: Consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 9. Calcitonin in the treatment of osteoporosis

AUTHOR(S)
Siminoski, Kerry; Josse, Robert G.
PUB. DATE
October 1996
SOURCE
CMAJ: Canadian Medical Association Journal;10/1/1996, Vol. 155 Issue 7, p962
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
35493979

 

Related Articles

  • 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. Brown, Jacques P.; Josse, Robert G. // CMAJ: Canadian Medical Association Journal;11/12/2002 Supplement, Vol. 167, pS1 

    Objective: To revise and expand the 1996 Osteoporosis Society of Canada clinical practice guidelines for the management of osteoporosis, incorporating recent advances in diagnosis, prevention and management of osteoporosis, and to identify and assess the evidence supporting the recommendations....

  • Are You at Risk for Osteoporosis?  // Clinical Diabetes;Summer2002, Vol. 20 Issue 3, p158 

    Examines the risk for osteoporosis. Signs of osteoporosis; Signs of osteoporosis; Ways of preventing osteoporosis; Treatment available for osteoporosis.

  • 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. Brown, Jacques P.; Josse, Robert G. // CMAJ: Canadian Medical Association Journal Supplement;11/12/2002 Osteoporosis, Vol. 167 Issue 10, ps1 

    Abstract Objective: To revise and expand the 1996 Osteoporosis Society of Canada clinical practice guidelines for the management of osteoporosis, incorporating recent advances in diagnosis, prevention and management of osteoporosis, and to identify and assess the evidence supporting the...

  • Drugs in Clinical Development for Osteoporosis.  // Pharmaceutical Medicine - New Zealand;2012, Vol. 26 Issue 4, p249 

    The article offers information on several drugs in clinical development for the treatment and management of osteoporosis. The skeletal disorder is said to be characterized by a loss of bone strength with an increased risk of fractures. Several types of osteoporosis are cited including...

  • Osteoporosis and calcitonin deficiency. Stevenson, John C.; White, Michael C.; Joplin, Graham F.; MacIntyre, Iain // British Medical Journal (Clinical Research Edition);10/9/1982, Vol. 285 Issue 6347, p1010 

    Examines the association between osteoporosis and calcitonin deficiency. Signs and symptoms of the disease; Treatment and management of the disease process; Development of osteoporosis after puberty.

  • Using Critical Analysis Skills to Evaluate a Debate on Osteoporosis. Fenton, Tanis R.. // Research Update;Dec2007, Vol. 14 Issue 4, p2 

    The article discusses the study that assesses the role of milk in the prevention and management of osteoporosis using critical analysis method. Findings reveal that adults who drink more decrease the rate of bone loss and have higher intakes of vitamins and minerals. Thus, adequate consumption...

  • Bears, bones and osteoporosis.  // Active Living;Nov2006, Vol. 15 Issue 6, p29 

    The article discusses a review by the Scientific Advisory Council of Osteoporosis Canada which concluded that treatment with parathyroid hormone could be effective for osteoporosis. Parathyroid hormone is produced by black bears after hibernation to overcome bone loss generated by several months...

  • FDA panel rejects continued marketing of calcitonin salmon for osteoporosis. Costa, Samantha // Endocrine Today;Apr2013, Vol. 11 Issue 4, p5 

    The article reports that the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee of the U.S. Food and Drug Administration (FDA) disapproved of calcitonin salmon nasal spray as treatment for osteoporosis in 2013.

  • Yes, men get osteoporosis too.  // Executive Health's Good Health Report;Sep99, Vol. 35 Issue 12, p7 

    Describes prevention and treatment strategies for osteoporosis.

  • The osteoporosis care gap in Canada. Papaioannou, A.; Giangregorio, L.; Kvern, B.; Boulos, P.; Ioannidis, G.; Adachi, J. D. // BMC Musculoskeletal Disorders;2004, Vol. 5, p11 

    Background: The presence of a fragility fracture is a major risk factor for osteoporosis, and should be an indicator for osteoporosis diagnosis and therapy. However, the extent to which patients who fracture are assessed and treated for osteoporosis is not clear. Methods: We performed a review...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics